Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile
Figure 7
Effect of antifungal treatment on fungal burden in G. mellonella infected with C. albicans or C. krusei.
Galleria mellonella larvae were infected with C. krusei ATCC 6258 (A, 5×106 cells/larva) or C. albicans SC5314 (B, 5×105 cells/larva) and CFUs recovered from G. mellonella. Black bars, no treatment, white bars, fluconazole (12 mg/kg), grey bars, amphotericin B (4 mg/kg).